Published in PLoS One on September 19, 2013
Severe community-acquired pneumonia: timely management measures in the first 24 hours. Crit Care (2016) 0.75
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med (1996) 35.00
A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA (1994) 27.36
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis (2007) 24.91
Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med (2010) 10.44
Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax (2003) 9.54
APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med (1981) 9.14
Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis (2000) 3.01
PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia. Crit Care Med (2009) 2.59
SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis (2008) 2.56
Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis (1991) 2.46
Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med (2008) 2.14
A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest (2007) 2.14
Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med (1998) 1.99
Severe community-acquired pneumonia. Risk factors and follow-up epidemiology. Am J Respir Crit Care Med (1999) 1.83
Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission. Clin Infect Dis (2009) 1.80
Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. Am J Respir Crit Care Med (2002) 1.78
Severe community-acquired pneumonia in ICUs: prospective validation of a prognostic score. Intensive Care Med (1996) 1.69
Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax (2004) 1.68
Ameba-associated microorganisms and diagnosis of nosocomial pneumonia. Emerg Infect Dis (2006) 1.66
Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia. Clin Infect Dis (1996) 1.64
Associations between empirical antimicrobial therapy at the hospital and mortality in patients with severe community-acquired pneumonia. Intensive Care Med (2002) 1.57
Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia. Intensive Care Med (1999) 1.55
Non-invasive ventilation in community-acquired pneumonia and severe acute respiratory failure. Intensive Care Med (2012) 1.49
Benefits and risks of success or failure of noninvasive ventilation. Intensive Care Med (2006) 1.40
Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality. Chest (2009) 1.40
A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med (1995) 1.32
Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia. Chest (2009) 1.22
Demographics, guidelines, and clinical experience in severe community-acquired pneumonia. Crit Care (2008) 1.10
Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study. Medicine (Baltimore) (2007) 1.08
A comparison of culture-positive and culture-negative health-care-associated pneumonia. Chest (2009) 1.07
Community-acquired pneumonia guidelines: a global perspective. Semin Respir Crit Care Med (2012) 0.98
The impact of a delay in intensive care unit admission for community-acquired pneumonia. Eur Respir J (2010) 0.96
Profiles of pyelonephritis. Arch Intern Med (1962) 0.90
Cytomegalovirus and herpes simplex virus effect on the prognosis of mechanically ventilated patients suspected to have ventilator-associated pneumonia. PLoS One (2012) 0.89
Outcomes of early, late, and no admission to the intensive care unit for patients hospitalized with community-acquired pneumonia. Acad Emerg Med (2012) 0.82
Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs clarithromycin: results from two randomized, double-blind, clinical trials. Curr Med Res Opin (2004) 0.81
How do we optimize outcomes for patients with severe community-acquired pneumonia? Intensive Care Med (2002) 0.79
Severe community-acquired pneumonia: how to assess illness severity. Monaldi Arch Chest Dis (1999) 0.76
Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis (2009) 16.51
Identification of rare pathogenic bacteria in a clinical microbiology laboratory: impact of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2013) 11.31
Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med (2010) 10.44
The 1.2-megabase genome sequence of Mimivirus. Science (2004) 8.37
Risk of post-traumatic stress symptoms in family members of intensive care unit patients. Am J Respir Crit Care Med (2005) 6.52
Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet (2007) 4.81
Amoebal coculture of "Mycobacterium massiliense" sp. nov. from the sputum of a patient with hemoptoic pneumonia. J Clin Microbiol (2004) 4.32
High level of burnout in intensivists: prevalence and associated factors. Am J Respir Crit Care Med (2007) 3.92
Burnout syndrome in critical care nursing staff. Am J Respir Crit Care Med (2006) 3.62
rpoB gene sequencing for identification of Corynebacterium species. J Clin Microbiol (2004) 3.24
Burnout syndrome among critical care healthcare workers. Curr Opin Crit Care (2007) 2.82
MALDI-TOF-mass spectrometry applications in clinical microbiology. Future Microbiol (2010) 2.79
De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med (2014) 2.77
Protective ventilation influences systemic inflammation after esophagectomy: a randomized controlled study. Anesthesiology (2006) 2.62
The louse-borne human pathogen Bartonella quintana is a genomic derivative of the zoonotic agent Bartonella henselae. Proc Natl Acad Sci U S A (2004) 2.61
Right ventricular function during high-frequency oscillatory ventilation in adults with acute respiratory distress syndrome. Crit Care Med (2012) 2.56
Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med (2004) 2.55
Giant Marseillevirus highlights the role of amoebae as a melting pot in emergence of chimeric microorganisms. Proc Natl Acad Sci U S A (2009) 2.52
Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis. Am J Respir Crit Care Med (2012) 2.45
Genome sequence of Rickettsia bellii illuminates the role of amoebae in gene exchanges between intracellular pathogens. PLoS Genet (2006) 2.35
Comparison of prone positioning and high-frequency oscillatory ventilation in patients with acute respiratory distress syndrome. Crit Care Med (2005) 2.30
Genome-based design of a cell-free culture medium for Tropheryma whipplei. Lancet (2003) 2.14
Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation. Intensive Care Med (2014) 2.12
Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology (2009) 2.11
Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest (2005) 2.05
Provirophages and transpovirons as the diverse mobilome of giant viruses. Proc Natl Acad Sci U S A (2012) 1.96
Comparison between rpoB and 16S rRNA gene sequencing for molecular identification of 168 clinical isolates of Corynebacterium. J Clin Microbiol (2005) 1.94
Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med (2009) 1.92
Early identification of patients at risk for difficult intubation in the intensive care unit: development and validation of the MACOCHA score in a multicenter cohort study. Am J Respir Crit Care Med (2013) 1.90
NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med (2005) 1.85
Modern clinical microbiology: new challenges and solutions. Nat Rev Microbiol (2013) 1.81
Acinetobacter baumannii resistant to colistin with impaired virulence: a case report from France. J Infect Dis (2011) 1.79
An Official ATS/ERS/ESICM/SCCM/SRLF Statement: Prevention and Management of Acute Renal Failure in the ICU Patient: an international consensus conference in intensive care medicine. Am J Respir Crit Care Med (2010) 1.77
Accuracy of the double indicator method for measurement of extravascular lung water depends on the type of acute lung injury. Crit Care Med (2004) 1.72
Ameba-associated microorganisms and diagnosis of nosocomial pneumonia. Emerg Infect Dis (2006) 1.66
High-frequency oscillatory ventilation following prone positioning prevents a further impairment in oxygenation. Crit Care Med (2007) 1.61
Tropheryma whipplei in patients with pneumonia. Emerg Infect Dis (2010) 1.59
The discovery and characterization of Mimivirus, the largest known virus and putative pneumonia agent. Clin Infect Dis (2007) 1.58
Noninvasive mechanical ventilation in patients having declined tracheal intubation. Intensive Care Med (2012) 1.56
Ectoparasitism and vector-borne diseases in 930 homeless people from Marseilles. Medicine (Baltimore) (2005) 1.56
Mimivirus shows dramatic genome reduction after intraamoebal culture. Proc Natl Acad Sci U S A (2011) 1.54
Ultrastructural characterization of the giant volcano-like virus factory of Acanthamoeba polyphaga Mimivirus. PLoS One (2007) 1.53
Phylogenetic and phyletic studies of informational genes in genomes highlight existence of a 4 domain of life including giant viruses. PLoS One (2010) 1.53
FIO2 and acute respiratory distress syndrome definition during lung protective ventilation. Crit Care Med (2009) 1.52
Ability of family members to predict patient's consent to critical care research. Intensive Care Med (2007) 1.50
Adrenal axis function does not appear to be associated with hemodynamic improvement in septic shock patients systematically receiving glucocorticoid therapy. Intensive Care Med (2006) 1.48
Long-term outcome in intensive care unit survivors after mechanical ventilation for intracerebral hemorrhage. Crit Care Med (2003) 1.48
Long-term outcome in medical patients aged 80 or over following admission to an intensive care unit. Crit Care (2011) 1.48
First isolation of Mimivirus in a patient with pneumonia. Clin Infect Dis (2013) 1.47
Viruses with more than 1,000 genes: Mamavirus, a new Acanthamoeba polyphaga mimivirus strain, and reannotation of Mimivirus genes. Genome Biol Evol (2011) 1.47
Prone position and positive end-expiratory pressure in acute respiratory distress syndrome. Crit Care Med (2003) 1.45
Interferon-γ production by natural killer cells and cytomegalovirus in critically ill patients. Crit Care Med (2012) 1.43
Bartonella quintana in human erythrocytes. Lancet (2002) 1.42
Molecular detection of microorganisms in distal airways of patients undergoing lung cancer surgery. Ann Thorac Surg (2011) 1.42
Nanobacteria are mineralo fetuin complexes. PLoS Pathog (2008) 1.42
Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med (2006) 1.41
"Megavirales", a proposed new order for eukaryotic nucleocytoplasmic large DNA viruses. Arch Virol (2013) 1.41
Related giant viruses in distant locations and different habitats: Acanthamoeba polyphaga moumouvirus represents a third lineage of the Mimiviridae that is close to the megavirus lineage. Genome Biol Evol (2012) 1.40
Acquiring procedural skills in ICUs: a prospective multicenter study*. Crit Care Med (2014) 1.40
A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients. Crit Care Med (2007) 1.39
Serological hint suggesting that Parachlamydiaceae are agents of pneumonia in polytraumatized intensive care patients. Ann N Y Acad Sci (2003) 1.38
Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care (2013) 1.36
Laboratory diagnosis of leptospirosis: a challenge. J Microbiol Immunol Infect (2013) 1.36
Genotyping reveals a wide heterogeneity of Tropheryma whipplei. Microbiology (2008) 1.35
Parachlamydiaceae as rare agents of pneumonia. Emerg Infect Dis (2003) 1.35
The rhizome of the multidrug-resistant Enterobacter aerogenes genome reveals how new "killer bugs" are created because of a sympatric lifestyle. Mol Biol Evol (2012) 1.34
Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center. Intensive Care Med (2013) 1.33
Extracorporeal membrane oxygenation for severe influenza A (H1N1) acute respiratory distress syndrome: a prospective observational comparative study. Intensive Care Med (2010) 1.32
Multi-pathogens sequence containing plasmids as positive controls for universal detection of potential agents of bioterrorism. BMC Microbiol (2004) 1.32
Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: a randomized,double-blind, placebo-controlled trial. Crit Care Med (2012) 1.28
Isolation of Bartonella rattimassiliensis sp. nov. and Bartonella phoceensis sp. nov. from European Rattus norvegicus. J Clin Microbiol (2004) 1.26
Amoebae-resisting bacteria isolated from human nasal swabs by amoebal coculture. Emerg Infect Dis (2004) 1.26